{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:49:03Z","timestamp":1787496543719,"version":"build-2736575974"},"reference-count":20,"publisher":"Tech Science Press","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1289,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1747-0803.2012.00635.x","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T04:40:58Z","timestamp":1329712858000},"page":"243-249","source":"Crossref","is-referenced-by-count":39,"title":["The Safety and Effects of Bosentan in Patients with a Fontan Circulation"],"prefix":"10.32604","volume":"7","author":[{"given":"Sarah E.","family":"Bowater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Clift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2012,2,20]]},"reference":[{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/01.CIR.85.2.469","article-title":"Five- to fifteen-year follow-up after Fontan operation","volume":"85","author":"Driscoll","year":"1992","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1093\/eurheartj\/ehq356","article-title":"Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients","volume":"31","author":"Diller","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1510\/icvts.2009.218594","article-title":"The Fontan circulation: who controls cardiac output?","volume":"10","author":"Gewillig","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.amjcard.2009.12.020","article-title":"Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving Fontan palliation","volume":"105","author":"Goldstein","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-5223(04)00991-2","article-title":"Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure","volume":"128","author":"Mitchell","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cct.2011.04.001","article-title":"Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?","volume":"32","author":"Schuuring","year":"2011","journal-title":"Contemp Clin Trials"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","article-title":"Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial","volume":"123","author":"Goldberg","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Gali\u00e8","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/hrt.2010.193912","article-title":"Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies","volume":"96","author":"Beghetti","year":"2010","journal-title":"Heart"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB14|cit14","unstructured":"Actelion Pharmaceuticals Ltd Tracleer (bosentan) Summary of Product Characteristics http:\/\/www.medicines.org.uk\/EMC\/medicine\/20423\/SPC\/Tracleer+(bosentan)+125mg+film-coated+tablets\/"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.healun.2004.11.018","article-title":"Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation","volume":"24","author":"Apostolopoulou","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1047951109990023","article-title":"The effect of bosentan in patients with a failing Fontan circulation","volume":"19","author":"Ovaert","year":"2009","journal-title":"Cardiol Young"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jtcvs.2010.03.023","article-title":"Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery","volume":"140","author":"Hirono","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1378\/chest.130.3.647","article-title":"Effect of fluticasone propionate\/salmeterol on lung hyperinflation and exercise endurance in COPD","volume":"130","author":"O'Donnell","year":"2006","journal-title":"Chest"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.rmed.2007.03.008","article-title":"Effect of tiotropium bromide on the cardiovascular response to exercise in COPD","volume":"101","author":"Travers","year":"2007","journal-title":"Respir Med"},{"key":"10.1111\/j.1747-0803.2012.00635.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1542\/peds.2009-2973","article-title":"Pediatric cardiac quality of life inventory testing study consortium. Validation of the pediatric cardiac quality of life inventory","volume":"126","author":"Marino","year":"2010","journal-title":"Pediatrics"}],"container-title":["Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1747-0803.2012.00635.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T18:01:09Z","timestamp":1588010469000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1747-0803.2012.00635.x"}},"subtitle":["Bosentan for Fontan Patients"],"short-title":[],"issued":{"date-parts":[[2012,2,20]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1747-0803.2012.00635.x","relation":{},"ISSN":["1747-079X"],"issn-type":[{"value":"1747-079X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2,20]]}}}